Business Context and Reporting Period
This Form 8-K Current Report was filed by Varex Imaging Corporation on January 10, 2023. The filing discloses executive leadership changes within the Detectors division and the terms of a Transition and Release Agreement.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and compensatory arrangements rather than financial performance.
Material Changes
- Executive Departure: Brian Giambattista will retire as Senior Vice President and General Manager, Detectors, effective March 31, 2023.
- Succession: Andrew Hartmann, currently Senior Vice President, Medical Sales and Marketing, will succeed Mr. Giambattista effective April 3, 2023.
- Role Vacancy: The Company will conduct a search to fill Mr. Hartmann's former role.
Management Commentary and Compensatory Arrangements
Mr. Giambattista entered into a Transition and Release Agreement on January 10, 2023. Key terms include:
- Transition Period (Jan 10, 2023 – Mar 31, 2023): Mr. Giambattista continues in his current capacity with full salary and benefits.
- Continued Employment Period (Apr 1, 2023 – Feb 28, 2025): Mr. Giambattista will serve as a non-executive employee reporting to the CEO. He will receive 50% of his prior annual salary and retain health insurance and other non-executive benefits.
- Equity: Prior equity awards will continue to vest during the Continued Employment Period, provided conditions are met. No new equity grants will be issued in fiscal year 2023 or thereafter.
- Restrictions: The agreement includes customary non-solicitation, non-compete, and non-disparagement provisions.
- Successor Compensation: Mr. Hartmann's compensation will not change materially upon his appointment.
Key Facts for Investor Verification
- Verify the impact of the leadership transition on the Detectors division's operational continuity.
- Review the attached Exhibit 10.1 (Transition and Release Agreement) for specific definitions of "Cause" and termination rights.
- Monitor the timeline for the search to fill the Senior Vice President, Medical Sales and Marketing role.
- Confirm that no other undisclosed arrangements exist regarding Mr. Hartmann's appointment as per Regulation S-K Item 401(b).